AGP Picks
View all

Airline Industry Today
Provided by AGP

Airline Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Airline Industry Today.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 29, 2026

Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock
Sep. 29, 2026

Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire
Boehringer Ingelheim investments into sustainability-related programs and health partnerships to reach EUR 500 million
Sep. 29, 2026

Boehringer Ingelheim investments into sustainability-related programs and health partnerships to reach EUR 500 million

Indeterminate GlobeNewswire
PolarityBio’s Phase 3 COVER DFUS II Trial Selected for First-to-Podium Presentation at SAWC Fall 2026
Sep. 29, 2026

PolarityBio’s Phase 3 COVER DFUS II Trial Selected for First-to-Podium Presentation at SAWC Fall 2026

Indeterminate GlobeNewswire
Ocugen to Participate in Upcoming October Investor and Industry Conferences
Sep. 29, 2026

Ocugen to Participate in Upcoming October Investor and Industry Conferences

Indeterminate GlobeNewswire
BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUBLIN-4 Trial Toward Planned Interim Analysis
Sep. 29, 2026

BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUBLIN-4 Trial Toward Planned Interim Analysis

Indeterminate GlobeNewswire
Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311
Sep. 29, 2026

Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311

Indeterminate GlobeNewswire
EliseAI Raises $350 Million at $4 Billion Valuation to Bring AI Deeper Into Housing and Healthcare Operations
Sep. 29, 2026

EliseAI Raises $350 Million at $4 Billion Valuation to Bring AI Deeper Into Housing and Healthcare Operations

Indeterminate GlobeNewswire
Aurora Mobile's GPTBots.ai Helps Ruko Cut Support Ticket Response Time from Two Hours to Under 10 Minutes
Sep. 29, 2026

Aurora Mobile's GPTBots.ai Helps Ruko Cut Support Ticket Response Time from Two Hours to Under 10 Minutes

Indeterminate GlobeNewswire
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
Sep. 29, 2026

Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites

Indeterminate GlobeNewswire
GXO and Columbia Sportswear Company Launch 10-Year Strategic Logistics Relationship in Europe
Sep. 29, 2026

GXO and Columbia Sportswear Company Launch 10-Year Strategic Logistics Relationship in Europe

Indeterminate GlobeNewswire
Why Weight Loss Plateaus Happen: 5 Metabolic Causes
Sep. 29, 2026

Why Weight Loss Plateaus Happen: 5 Metabolic Causes

Indeterminate GlobeNewswire
ABBYY Appoints Paula Sanders to Chief Customer Experience Officer, Providing Customers a Single, End-to-End Experience
Sep. 29, 2026

ABBYY Appoints Paula Sanders to Chief Customer Experience Officer, Providing Customers a Single, End-to-End Experience

Indeterminate GlobeNewswire
REalloys Provides Update on Appointment of Dr. Muhammad Imran as Chief Operating Officer
Sep. 29, 2026

REalloys Provides Update on Appointment of Dr. Muhammad Imran as Chief Operating Officer

Indeterminate GlobeNewswire
NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer
Sep. 29, 2026

NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer

Indeterminate GlobeNewswire
First Quantum Provides Notice of Third Quarter 2026 Results
Sep. 29, 2026

First Quantum Provides Notice of Third Quarter 2026 Results

Indeterminate GlobeNewswire
Sable Announces Moxico-Funded Exploration Program and 3,500m Drill Program at the El Fierro Project, San Juan, Argentina
Sep. 29, 2026

Sable Announces Moxico-Funded Exploration Program and 3,500m Drill Program at the El Fierro Project, San Juan, Argentina

Indeterminate GlobeNewswire
Cascade Prodrug Inc. Appoints Kenneth Mandell, M.D., Ph.D. to Board of Directors
Sep. 29, 2026

Cascade Prodrug Inc. Appoints Kenneth Mandell, M.D., Ph.D. to Board of Directors

Indeterminate GlobeNewswire
Halcones Precious Metals Provides Update on Surface Rights Access for the Polaris Project
Sep. 29, 2026

Halcones Precious Metals Provides Update on Surface Rights Access for the Polaris Project

Indeterminate GlobeNewswire
PyroGenesis Completes Acquisition of 50% Ownership Interest in HPQ Silica Polvere Inc., Rights-Holder of the Fumed Silica Reactor Technology
Sep. 29, 2026

PyroGenesis Completes Acquisition of 50% Ownership Interest in HPQ Silica Polvere Inc., Rights-Holder of the Fumed Silica Reactor Technology

Indeterminate GlobeNewswire
Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer
Sep. 29, 2026

Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Airline Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.